Maintenance low-dose capecitabine versus observation in early-stage triple-negative breast cancer: a randomized controlled trial assessing safety with exploratory survival outcomes

Abstract Background Triple-negative breast cancer (TNBC) carries a worse prognosis primarily because it does not have specific targeted therapies and is biologically aggressive, leading to a great probability of early relapse, especially involving visceral sites. At present, standard chemotherapy is...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Sarah Hamdy Ali, Enas Mohsen El Nadi, Abeer Mokhles Gadallah, Ahmad Mahrous Dewidar, Engy A. Wahsh, Ahmed Hassan Shaaban
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	SpringerOpen 2026-04-01
Цуврал:	Future Journal of Pharmaceutical Sciences
Нөхцлүүд:	Triple-negative breast cancer Maintenance capecitabine Early-stage breast cancer Disease-free survival Overall survival
Онлайн хандалт:	https://doi.org/10.1186/s43094-026-00964-1
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!